From the Journals
From the Journals
New tool guides nutrition counseling in schizophrenia patients
“Eating well for mental health is part of self-care and can be included in mental health treatment plans,” said lead author Dr. Laura LaChance.
From the Journals
Swell in off-label antipsychotic prescribing ‘not harmless’
Clinicians should be made aware that low-dose treatment with these drugs for insomnia and anxiety “might come at a cost of shortening patients’...
From the Journals
COVID-19 mortality risk factors: An unexpected finding
“Once [patients with severe psychiatric illness] have the infection, they are more prone to worse outcomes,” said Dr. Antonio L. Teixeira.
News
AAN issues ethical guidance on controversial Alzheimer’s drug
The statement aims to help clinicians communicate the uncertainty over aducanumab’s risks and potential benefits.
From the Journals
Short-acting opioids needed for withdrawal in U.S. hospitals, say experts
The short-acting drugs can complement methadone and buprenorphine to help patients get faster relief and help patients stay in the hospital to...
From the Journals
Social media use associated with depression in adults
New data on adults reflects the link between social media and depression seen in youths.
From the Journals
Ferric carboxymaltose calms restless legs
Nearly two-thirds of patients with restless legs syndrome remained off RLS medications at 1 year after treatment.
From the Journals
Lithium’s antisuicidal effects questioned
The researchers note that the study did not reach its original recruitment goal.
From the Journals
Transdermal patches ease extrapyramidal symptoms in schizophrenia
Schizophrenia patients who switched from blonanserin tablets to patches showed significant reduction in extrapyramidal symptoms but not in use of...
From the Journals
Mask-wearing cuts new COVID-19 cases by 53%, study says
Social distancing and handwashing were also effective at lowering the number of cases, but wearing masks was the most effective tool against the...
From the Journals
Growing evidence supports repurposing antidepressants to treat COVID-19
“We can’t tell if the drugs are causing these effects, but the statistical analysis is showing significant association,” said Dr. Marina Sirota....